Stay updated on AK104 Plus Anlotinib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.

Latest updates to the AK104 Plus Anlotinib in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry (v3.4.2) was added to the record history; the funding notice and the prior Revision v3.4.1 entry were removed.SummaryDifference0.9%

- Check21 days agoChange DetectedThe page adds a site-wide funding notice banner. It also records a new revision (v3.4.1) in the history, replacing the previous v3.4.0.SummaryDifference0.9%

- Check28 days agoChange DetectedGlossary display and color-coded change indicators (green for additions, red for deletions) were added to the Record History page. The revision banner now shows Revision: v3.4.0, replacing the previous version.SummaryDifference1%

- Check35 days agoChange DetectedThe Study Record Versions list now includes a new entry for Revision: v3.3.4, indicating a minor update to the page history rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the record history, and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer. These changes are administrative and do not affect study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedA new revision entry v3.3.2 has been added to the Record History, and v3.3.1 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AK104 Plus Anlotinib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.